Artwork

Content provided by Cain Brothers, a division of KeyBanc Capital Markets, Cain Brothers, and A division of KeyBanc Capital Markets. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cain Brothers, a division of KeyBanc Capital Markets, Cain Brothers, and A division of KeyBanc Capital Markets or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Future of Clinical Trials: Decentralized, Diversified, Efficient and Fast

23:30
 
Share
 

Manage episode 275610327 series 2784634
Content provided by Cain Brothers, a division of KeyBanc Capital Markets, Cain Brothers, and A division of KeyBanc Capital Markets. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cain Brothers, a division of KeyBanc Capital Markets, Cain Brothers, and A division of KeyBanc Capital Markets or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The race to develop a COVID-19 vaccine has put the clinical trial process under the microscope. Cain Brothers Managing Director, John Kerins, talks with Dave Johnson about innovations in clinical trials that reduce the barriers to participation, improve the diversity of patient populations, and accelerate the development of safe and effective vaccines.

Cain Brothers is a division of KeyBanc Capital Markets.

  continue reading

66 episodes

Artwork
iconShare
 
Manage episode 275610327 series 2784634
Content provided by Cain Brothers, a division of KeyBanc Capital Markets, Cain Brothers, and A division of KeyBanc Capital Markets. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cain Brothers, a division of KeyBanc Capital Markets, Cain Brothers, and A division of KeyBanc Capital Markets or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The race to develop a COVID-19 vaccine has put the clinical trial process under the microscope. Cain Brothers Managing Director, John Kerins, talks with Dave Johnson about innovations in clinical trials that reduce the barriers to participation, improve the diversity of patient populations, and accelerate the development of safe and effective vaccines.

Cain Brothers is a division of KeyBanc Capital Markets.

  continue reading

66 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play